NCT06301828View on ClinicalTrials.gov

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

PHASE2RecruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

February 21, 2024

Primary Completion Date

June 21, 2025

Study Completion Date

February 21, 2026

Conditions
Gastrointestinal Neoplasms
Interventions
DRUG

Envafolimab Injection

Endostar+SBRT+Envafolimab Injection

DRUG

Endostar

Endostar+SBRT+Envafolimab Injection

Trial Locations (1)

210006

RECRUITING

Nanjing First Hospital, Nanjing

All Listed Sponsors
lead

Nanjing First Hospital, Nanjing Medical University

OTHER